Summary & Overview

HCPCS G9703: Antibiotic Use in 30 Days Prior to Episode

HCPCS Level II code G9703 denotes episodes in which a patient was taking antibiotics listed in Table 1 within the 30 days prior to the episode date. Nationally, documenting recent antibiotic exposure matters for clinical decision-making, quality measurement, and risk stratification because prior antibiotic use can affect infection risk, antimicrobial stewardship, and care pathways. This code standardizes capture of that exposure across care settings.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of how G9703 is used to record recent antibiotic therapy, the typical service context (medication exposure assessment in outpatient and inpatient settings), and the implications for claims reporting and quality programs. The publication also provides benchmarks and comparisons where available, notes on common billing modifiers, and clinical context related to antibiotic exposure. Data not available in the input is clearly identified so readers understand which fields require local validation or additional sources.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9703HCPCS Level IIantibiotic exposuremedication assessmentquality measurementantimicrobial stewardshipoutpatient careinpatient care

Billing Code Overview

HCPCS Level II code G9703 represents episodes where the patient is taking antibiotics from Table 1 in the 30 days prior to the episode date. This code captures medication exposure related to antibiotic therapy in the month before an episode.

Service type: Medication exposure assessment
Typical site of service: Outpatient or inpatient clinical settings where antibiotic use is documented prior to an episode

Clinical & Coding Specifications

Clinical Context

A typical patient scenario involves an adult patient who presents for evaluation of a non-surgical condition (for example, a suspected urinary tract infection, skin infection, or respiratory infection) and who has been taking systemic antibiotics within the 30 days prior to the documented episode date. The clinical workflow begins with triage and history-taking documenting current medications and confirming antibiotic use within the prior 30 days. The clinician documents the specific antibiotic agent, start and stop dates, and indication. Clinical assessment may include targeted physical exam, collection of specimens for culture or rapid testing, and diagnostic imaging or laboratory studies as indicated. The episode date is the date of the clinical encounter for which the presence of recent antibiotic therapy is reported and is captured for quality measurement or risk adjustment. Typical sites of service include outpatient clinic, urgent care, emergency department, and skilled nursing facility visits where documentation of recent antibiotics influences infection management, stewardship decisions, or quality reporting.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when additional work or complexity is documented beyond usual for the encounter where antibiotic use impacts management complexity.
`23`	Unusual anesthesia	Use when an encounter requires unusual anesthesia related to procedures performed in the presence of recent antibiotic therapy.
`52`	Reduced services	Use when a planned service is partially reduced during the episode influenced by recent antibiotic therapy.
`53`	Discontinued procedure	Use when a procedure is started but halted due to issues related to recent antibiotic therapy or allergy concerns.
`54`	Surgical care only	Use for the surgeon’s portion when postoperative or related follow-up is impacted by recent antibiotics.
`55`	Postoperative management only	Use for postoperative care when antibiotic exposure is a factor in ongoing management.
`56`	Preoperative management only	Use when preoperative evaluation is provided and recent antibiotic use alters clearance or risk.
`62`	Two surgeons	Use when two surgeons are required, potentially due to infection complexity from recent antibiotic exposure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery	Use when these clinicians assist and antibiotic-related considerations affect intraoperative or perioperative care.
`QK`	Medical direction of two, three, or four technicians by a physician	Use when physician medical direction is documented for services where recent antibiotics affect technician-performed testing.
`QX`	Qualified non-physician health care professional independently providing services	Use when a qualified non-physician documents and provides services impacted by recent antibiotic therapy.
`QY`	Supportive non-physician health care professional service under physician supervision	Use for supervised non-physician services where antibiotic history informs care decisions.

Taxonomy Code	Specialty	Notes
`208D00000X`	Family Medicine	Primary care clinicians who document recent antibiotic use during outpatient encounters.
`207Q00000X`	Emergency Medicine	Emergency clinicians who evaluate infections and document pre-encounter antibiotic therapy.
`207L00000X`	Infectious Disease	Specialists involved when recent antibiotic exposure affects diagnosis, culture interpretation, or stewardship decisions.
`1835F0001X`	Nurse Practitioner	Advanced practice clinicians who document medication history and manage common infections.
`207P00000X`	Internal Medicine	Hospitalists and internists documenting recent antibiotic use in inpatient or clinic episodes.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J01.90`	Acute sinusitis, unspecified	Common infection for which prior antibiotic use within 30 days may affect treatment choice or resistance considerations.
`J02.9`	Acute pharyngitis, unspecified	Prior antibiotics may indicate treatment failure or alternative diagnosis and influence testing and management.
`N39.0`	Urinary tract infection, site not specified	Recent antibiotic exposure can alter urine culture results and guide selection of empiric therapy.
`L03.90`	Cellulitis, unspecified	Prior antibiotics can change microbiology and may indicate resistant organisms or need for specialist consultation.
`J18.9`	Pneumonia, unspecified organism	Recent antibiotic therapy may affect sputum culture yield and antibiotic stewardship decisions.
`A49.9`	Bacterial infection, unspecified	Used when a bacterial infection is diagnosed but organism is not specified; prior antibiotics influence diagnostic interpretation.
`R05`	Cough	Symptom code used when investigating respiratory complaints where recent antibiotics are relevant to differential diagnosis.
`B95.61`	Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere	Relevant when prior antibiotic exposure raises concern for resistant or persistent Staphylococcus infections.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87070`	Culture, bacterial; any other source except urine, blood, stool or semen	Performed when antibiotic exposure may alter culture yield; used to obtain microbiology for guiding therapy.
`87081`	Cultures, bacterial; screening only, urine	Performed for suspected urinary tract infection where recent antibiotics could affect results.
`87491`	Infectious agent detection by nucleic acid (DNA or RNA); COVID-19, amplified probe technique, single step	Used when recent antibiotics are noted but viral testing is indicated to differentiate causes of symptoms.
`87086`	Culture, bacterial; urine, routine, with isolation and presumptive identification of isolates	Ordered when urine culture is needed and recent antibiotic exposure may suppress growth, influencing interpretation.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Used when an injected antibiotic or other medication is administered during the encounter and prior oral antibiotic use is documented.